Self-Assembled Coumarin Nanoparticle in Aqueous Solution as Selective Mitochondrial-Targeting Drug Delivery System
- 16 January 2018
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 10 (4) , 3380-3391
Abstract
The development of specifically targeted nanoparticles for subcellular organelles modified with a low-molecular-weight organic compound as drug nanocarriers can bring about wide applications in cancer therapy. However, their utility has been hampered by low selectivity, poor biodistribution, and limited efficiency. Herein, we report the aggregation behavior of a triphenyl phosphonium-appended coumarin probe (TPP-C) in aqueous solution and its applications as a mitochondria-targeting probe, and drug delivery carrier, which is a rare example for a low molecular-weight organic compound. TPP-C formed homogeneous nanoparticles with small diameters in water as well as in mixtures of organic solvents and water. In pure water, the homogeneous nanoparticles induced J-aggregation, while in mixed solvents, the homogeneous nanoparticles induced H-aggregation. The luminescence intensities of nanoparticles originated from the aggregation-induced emission (AIE) effect in pure water and also in mixtures of organic solvents and water. These findings indicate that the AIE effect of TPP-C was dependent on the solvent. More interestingly, TPP-C nanoparticles selectively accumulated in mitochondria. The TPP-C nanoparticles alone exhibited non-cytotoxicity toward cancer cells. However, with the encapsulation of the anticancer drug doxorubicin (DOX) into TPP-C nanoparticles, DOX was efficiently delivered to the mitochondria. These results indicated that the proposed system demonstrates promise as a platform for future clinical medication, particularly for specific sub-organelle-targeted drug delivery systems for cancer therapy.Keywords
Funding Information
- National Research Foundation of Korea (2017R1A4A1014595)
- Next-Generation BioGreen 21 Program (PJ01318605)
This publication has 56 references indexed in Scilit:
- Organelle targeting: third level of drug targetingDrug Design, Development and Therapy, 2013
- Mechanistic Evaluation of a Novel Small Molecule Targeting Mitochondria in Pancreatic Cancer CellsPLOS ONE, 2013
- Engineering of blended nanoparticle platform for delivery of mitochondria-acting therapeuticsProceedings of the National Academy of Sciences, 2012
- Liposomes loaded with paclitaxel and modified with novel triphenylphosphonium-PEG-PE conjugate possess low toxicity, target mitochondria and demonstrate enhanced antitumor effects in vitro and in vivoJournal of Controlled Release, 2012
- Selective Uncoupling of Individual Mitochondria within a Cell Using a Mitochondria-Targeted Photoactivated ProtonophoreJournal of the American Chemical Society, 2011
- A Targetable Fluorescent Sensor Reveals That Copper-Deficient SCO1 and SCO2 Patient Cells Prioritize Mitochondrial Copper HomeostasisJournal of the American Chemical Society, 2011
- When electrons and protons get excitedProceedings of the National Academy of Sciences, 2011
- Preclinical Evaluation of Novel Triphenylphosphonium Salts with Broad-Spectrum ActivityPLOS ONE, 2010
- Subcellular targeting strategies for drug design and deliveryNature Reviews Drug Discovery, 2010
- Quantitative Colocalization Analysis of Multicolor Confocal Immunofluorescence Microscopy Images: Pushing Pixels to Explore Biological PhenomenaACTA HISTOCHEMICA ET CYTOCHEMICA, 2007